Health
Economic burden of acute myeloid leukemia treatment | JBM – Dove Medical Press
What does the economic burden of acute myeloid leukemia treatment look like for the next decade? An analysis of key findings, challenges and recommendations
AML: A Rare and Costly Cancer
Acute myeloid leukemia (AML) arises in the bone marrow from the abnormal clonal expansion of myeloid blood cell precursors. Leukemic blast cells are found in the circulating blood as well as in the bone marrow, where they disrupt normal blood cell production, leading to myelosuppression.1 Consequences of AML include anemia, with weakness and pallor, thrombocytopenia, resulting in bleeding, and leukopenia, leading to fever and infection.
AML, which accounts for about…
-
Business22 hours agoHow I’d invest in ASX 200 shares if I wanted to sleep well during market volatility
-
Noosa News23 hours agoLockyer Valley man accused of killing wife allegedly staged mower crash scene, court hears
-
Noosa News23 hours agoFather and son from the UK killed, local man in critical condition after Seventeen Seventy beach tragedy
-
General22 hours agoSearch for driver in Parramatta River after car hit woman before going into water